NeurAxis (NRXS) Stock Analysis

What NeurAxis does

NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.

Key metrics

ETFs linked to NRXS

Broad-market and Healthcare sector ETFs an investor holding NeurAxis is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NRXS fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for NeurAxis?

NeurAxis trades under the ticker NRXS on AMEX.

Which exchange is NRXS listed on?

NRXS is listed on AMEX.

What sector does NeurAxis operate in?

NeurAxis is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze NRXS in a portfolio?

PortView shows NRXS's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.